Skip to main content
. Author manuscript; available in PMC: 2021 Jul 12.
Published in final edited form as: Med. 2021 Jul 9;2(7):851–863.e3. doi: 10.1016/j.medj.2021.04.011

Figure 3: Prospective liver-related and cardiovascular mortality as a function of MTARC1 rs2642438 genotype in the UKB.

Figure 3:

Liver-related mortality was defined as death due to liver diseases or hepatocellular carcinoma. (A) Liver-related mortality in the UKB population as a function of MTARC1 genotype. Participants were followed prospectively from the time of study entry until death or end of follow-up. (B) Cardiovascular mortality in the UKB population as a function of MTARC1 genotype. Hazard ratios were calculated by Cox regression, adjusted for age, sex, BMI, and PC1-4. Hazard ratios: 3A) HR homozygotes vs. non-carrier: 0.61[0.46-0.81]; HR heterozygotes vs. non-carrier: 0.85 [0.74-0.98].